F2

Gushengtang Holdings LtdFRA Gushengtang Stock Report

Last reporting period 30 Jun, 2023

Updated 12 Nov, 2024

Last price

Market cap $B

0.859

Micro

Exchange

XFRA - Deutsche Boerse AG

F2P.F Stock Analysis

F2

Uncovered

Gushengtang Holdings Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.859

Dividend yield

1.46 %

Shares outstanding

230.4 B

Gushengtang Holdings Ltd. operates the neo-TCM primary care platform, which combines inviting in-person care and seamless digital health powered by internet and AI technologies. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2021-12-10. The firm operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The firm's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The firm also provides honey, Ejiao cake and other nutritional products.

View Section: Eyestock Rating